Samta Kundu

Executive Officer at Strand Therapeutics.

Raised on Strand Therapeutics filings

$108.1M

of $120.1M offered across 1 Form D filing

Company

Boston, MA

Programmable mRNA therapies for solid tumors

Programmable mRNA therapies for solid tumors

Strand Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Mar 17, 2026	Equity	$108.1M/ $120.1M	Form D

Also named on Strand Therapeutics filings